136 related articles for article (PubMed ID: 25002294)
1. Elevation of soluble intercellular adhesion molecule-1 levels, but not angiopoietin 2, in the plasma of human immunodeficiency virus-infected African women with clinical Kaposi sarcoma.
Graham SM; Rajwans N; Richardson BA; Jaoko W; McClelland RS; Overbaugh J; Liles WC
Am J Trop Med Hyg; 2014 Oct; 91(4):705-8. PubMed ID: 25002294
[TBL] [Abstract][Full Text] [Related]
2. Endothelial activation biomarkers increase after HIV-1 acquisition: plasma vascular cell adhesion molecule-1 predicts disease progression.
Graham SM; Rajwans N; Jaoko W; Estambale BB; McClelland RS; Overbaugh J; Liles WC
AIDS; 2013 Jul; 27(11):1803-13. PubMed ID: 23807276
[TBL] [Abstract][Full Text] [Related]
3. Detection of Kaposi's sarcoma-associated herpesvirus in peripheral blood cells in human immunodeficiency virus infection: association with Kaposi's sarcoma, CD4 cell count, and HIV RNA levels.
Min J; Katzenstein DA
AIDS Res Hum Retroviruses; 1999 Jan; 15(1):51-5. PubMed ID: 10024052
[TBL] [Abstract][Full Text] [Related]
4. Immune reconstitution inflammatory syndrome associated with Kaposi sarcoma: higher incidence and mortality in Africa than in the UK.
Letang E; Lewis JJ; Bower M; Mosam A; Borok M; Campbell TB; Naniche D; Newsom-Davis T; Shaik F; Fiorillo S; Miro JM; Schellenberg D; Easterbrook PJ
AIDS; 2013 Jun; 27(10):1603-13. PubMed ID: 23462220
[TBL] [Abstract][Full Text] [Related]
5. A prospective study of endothelial activation biomarkers, including plasma angiopoietin-1 and angiopoietin-2, in Kenyan women initiating antiretroviral therapy.
Graham SM; Rajwans N; Tapia KA; Jaoko W; Estambale BB; McClelland RS; Overbaugh J; Liles WC
BMC Infect Dis; 2013 Jun; 13():263. PubMed ID: 23734875
[TBL] [Abstract][Full Text] [Related]
6. The clinical application of plasma Kaposi sarcoma herpesvirus viral load as a tumour biomarker: results from 704 patients.
Haq IU; Dalla Pria A; Papanastasopoulos P; Stegmann K; Bradshaw D; Nelson M; Bower M
HIV Med; 2016 Jan; 17(1):56-61. PubMed ID: 26111246
[TBL] [Abstract][Full Text] [Related]
7. Kaposi's Sarcoma in HIV-infected patients in South Africa: Multicohort study in the antiretroviral therapy era.
Bohlius J; Valeri F; Maskew M; Prozesky H; Garone D; Sengayi M; Fox MP; Davies MA; Egger M
Int J Cancer; 2014 Dec; 135(11):2644-52. PubMed ID: 24729433
[TBL] [Abstract][Full Text] [Related]
8. Detection and quantification of Kaposi's sarcoma-associated herpesvirus to predict AIDS-associated Kaposi's sarcoma.
Engels EA; Biggar RJ; Marshall VA; Walters MA; Gamache CJ; Whitby D; Goedert JJ
AIDS; 2003 Aug; 17(12):1847-51. PubMed ID: 12891072
[TBL] [Abstract][Full Text] [Related]
9. Association Between Immunoglobulin E Levels and Kaposi Sarcoma in African Adults With Human Immunodeficiency Virus Infection.
Byakwaga H; Barbachano-Guerrero A; Wang D; McAllister S; Naphri K; Laker-Oketta M; Muzoora C; Hunt PW; Martin J; King CA
J Infect Dis; 2021 Jan; 223(1):101-108. PubMed ID: 32561934
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for Kaposi's sarcoma in men seropositive for both human herpesvirus 8 and human immunodeficiency virus.
Cannon MJ; Dollard SC; Black JB; Edlin BR; Hannah C; Hogan SE; Patel MM; Jaffe HW; Offermann MK; Spira TJ; Pellett PE; Gunthel CJ
AIDS; 2003 Jan; 17(2):215-22. PubMed ID: 12545082
[TBL] [Abstract][Full Text] [Related]
11. Similar Immunological Profiles Between African Endemic and Human Immunodeficiency Virus Type 1-Associated Epidemic Kaposi Sarcoma (KS) Patients Reveal the Primary Role of KS-Associated Herpesvirus in KS Pathogenesis.
Lidenge SJ; Tso FY; Ngalamika O; Ngowi JR; Mortazavi Y; Kwon EH; Shea DM; Minhas V; Mwaiselage J; Wood C; West JT
J Infect Dis; 2019 Apr; 219(8):1318-1328. PubMed ID: 30452681
[TBL] [Abstract][Full Text] [Related]
12. Serum levels of intercellular adhesion molecule 1 in patients with HIV-related Kaposi's sarcoma.
De Paoli P; Caffau C; D'Andrea M; Tavio M; Tirelli U; Santini G
J Acquir Immune Defic Syndr (1988); 1994 Jul; 7(7):695-9. PubMed ID: 7911526
[TBL] [Abstract][Full Text] [Related]
13. Effect of human immunodeficiency virus-1 protease inhibitors on the clearance of human herpesvirus 8 from blood of human immunodeficiency virus-1-infected patients.
Leao JC; Kumar N; McLean KA; Porter SR; Scully CM; Swan AV; Teo CG
J Med Virol; 2000 Dec; 62(4):416-20. PubMed ID: 11074468
[TBL] [Abstract][Full Text] [Related]
14. Human Herpes Virus 8 in HIV-1 infected individuals receiving cancer chemotherapy and stem cell transplantation.
Hogan LE; Hanhauser E; Hobbs KS; Palmer CD; Robles Y; Jost S; LaCasce AS; Abramson J; Hamdan A; Marty FM; Kuritzkes DR; Henrich TJ
PLoS One; 2018; 13(5):e0197298. PubMed ID: 29746555
[TBL] [Abstract][Full Text] [Related]
15. Kaposi sarcoma: no longer an AIDS-defining illness? A retrospective study of Kaposi sarcoma cases with CD4 counts above 300/mm³ at presentation.
Daly ML; Fogo A; McDonald C; Morris-Jones R
Clin Exp Dermatol; 2014 Jan; 39(1):7-12. PubMed ID: 23691969
[TBL] [Abstract][Full Text] [Related]
16. Viral profiling identifies multiple subtypes of Kaposi's sarcoma.
Hosseinipour MC; Sweet KM; Xiong J; Namarika D; Mwafongo A; Nyirenda M; Chiwoko L; Kamwendo D; Hoffman I; Lee J; Phiri S; Vahrson W; Damania B; Dittmer DP
mBio; 2014 Sep; 5(5):e01633-14. PubMed ID: 25249280
[TBL] [Abstract][Full Text] [Related]
17. Treatment response and mortality among patients starting antiretroviral therapy with and without Kaposi sarcoma: a cohort study.
Maskew M; Fox MP; van Cutsem G; Chu K; Macphail P; Boulle A; Egger M; Africa FI
PLoS One; 2013; 8(6):e64392. PubMed ID: 23755122
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of plasma human herpesvirus 8 DNA as a marker of clinical outcomes during antiretroviral therapy for AIDS-related Kaposi sarcoma in Zimbabwe.
Borok M; Fiorillo S; Gudza I; Putnam B; Ndemera B; White IE; Gwanzura L; Schooley RT; Campbell TB
Clin Infect Dis; 2010 Aug; 51(3):342-9. PubMed ID: 20572760
[TBL] [Abstract][Full Text] [Related]
19. Reduced levels of neutralizing antibodies to Kaposi sarcoma-associated herpesvirus in persons with a history of Kaposi sarcoma.
Kimball LE; Casper C; Koelle DM; Morrow R; Corey L; Vieira J
J Infect Dis; 2004 Jun; 189(11):2016-22. PubMed ID: 15143468
[TBL] [Abstract][Full Text] [Related]
20. Acquired immunodeficiency syndrome-related Kaposi's sarcoma regression after highly active antiretroviral therapy: biologic correlates of clinical outcome.
Cattelan AM; Calabrò ML; Gasperini P; Aversa SM; Zanchetta M; Meneghetti F; De Rossi A; Chieco-Bianchi L
J Natl Cancer Inst Monogr; 2001; (28):44-9. PubMed ID: 11158206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
